First Bancshares Inc (Missouri)
Change company Symbol lookup
Select an option...
FBSI First Bancshares Inc (Missouri)
KGDEY Kingdee International Software Group Co Ltd
CMRA Comera Life Sciences Holdings Inc
ADI Analog Devices Inc
KEY KeyCorp
FNF Fidelity National Financial Inc
CTAQU Carney Technology Acquisition Corp. II
MUE BlackRock MuniHoldings Quality Fund II, Inc.
NC NACCO Industries Inc
RXT Rackspace Technology Inc
Go

Company profile

First Bancshares, Inc. is a holding company of First Home Savings Bank (the Bank). The Bank provides its customers with a full range of community banking services. The Bank is primarily engaged in the business of attracting deposits from, and making loans to, the general public, including individuals and businesses. The Bank originates real estate loans, including one-to-four family residential mortgage loans, multi-family residential loans, commercial real estate loans, agricultural real estate loans and home equity loans, as well as, non-real estate loans, including commercial business, agricultural business, and consumer loans. The Bank also invests in mortgage-back securities, United States government and agency securities, and other assets.

Price
Delayed
$17.87
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Heavy Day)

Today's volume of 1,121 shares is on pace to be much greater than FBSI's 10-day average volume of 781 shares.

1,121

Psychedelic drug treatment company Numinus buys Novamind in all-stock deal

11:02 am ET April 13, 2022 (MarketWatch)
Print

Numinus Wellness Inc. said Wednesday it'll pay about C$26.2 million ($21 million) in stock to buy Novamind Inc. to create a leading psychedelic-assisted wellness company. After the deal closes, Numinus Wellness will operate 13 wellness clinics, including eight in the U.S., with about C$10 million ($8 million) in annual revenue based on projects from the last four quarters. Numinus CEO Payton Nyquvest said the two companies have been aware of each other for a long time and decided to combine to accelerate growth. Novamind shareholders will receive 0.84 of a common share of Numinus for each Novamind share held. The deal implies an offer price of 44 cents per Novamind share, a premium of 51% to Novamind's 20-day volume-weighted average price on the Canadian Securities Exchange as of April 8. Novamind shareholders will hold 18% ownership in the combined company. Shares of Novamind are down 46.8% so far in 2022 and Numinus Wellness shares have lost 2.6%.

-Steve Gelsi

	

(END) Dow Jones Newswires

April 13, 2022 11:02 ET (15:02 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.